Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Bio Rad Laboratories Inc BIO

Alternate Symbol(s):  BIO.B

Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and... see more

Recent & Breaking News (NYSE:BIO)

Delix Therapeutics Announces Scientific & Strategic Advisory Board Appointments

PR Newswire June 4, 2021

Curis to Host Virtual Event to Discuss Updated Clinical Data for CA-4948 in AML/MDS Presented at EHA

PR Newswire June 4, 2021

FDA Authorizes Lower 1,200 mg Intravenous and Subcutaneous Dose of REGEN-COV(TM) (casirivimab and imdevimab) Antibody Cocktail to Treat Patients with COVID-19

PR Newswire June 4, 2021

Alligator Bioscience presents positive Phase I data at ASCO for its 4-1BB agonist drug candidate ATOR-1017

PR Newswire June 4, 2021

Elekta Nomination Committee's proposed Board of Directors for the 2021 Annual General Meeting

PR Newswire June 4, 2021

Sanofi partnering with leading academic cooperative groups to study amcenestrant in the adjuvant setting for patients with estrogen receptor positive breast cancer

PR Newswire June 4, 2021

Antengene Announces Publication of Abstract on XPO1 Inhibitor Selinexor in Relapsed or Refractory Multiple Myeloma at ASCO 2021 and EHA 2021

PR Newswire June 3, 2021

Alkermes to Take Part in the Goldman Sachs Annual Global Healthcare Conference

PR Newswire June 3, 2021

The Valens Company Enters Flower, Pre-Roll Categories and Introduces New Edibles and Concentrates Products in Partnership With Verse Cannabis

Canada NewsWire June 3, 2021

LifeX Labs, Pittsburgh Life Sciences Greenhouse Collaborate on Life Sciences Accelerator

PR Newswire June 3, 2021

AGBT Precision Health Goes Hybrid for Sixth Annual Meeting

PR Newswire June 3, 2021

Molecules in Saliva May Hold the Key to Tracking Improvements in Autism

PR Newswire June 3, 2021

Helix Announces $50 Million Series C Funding to Continue Acceleration into Clinical Population Genomics and COVID-19 Viral Surveillance

PR Newswire June 3, 2021

Pace International LLC Promotes Michelle Smith to Senior Manager, Sales and Field Services South US

PR Newswire June 3, 2021

The first hormone replacement therapy for hypoparathyroidism in China obtains IND approval for Phase III clinical trial

PR Newswire June 3, 2021

ImaginAb completes $12.8 million financing to accelerate growth plans

PR Newswire June 3, 2021

FDA Alerts Health Care Providers to Stop New Implants of Certain Ventricular Assist Device System

PR Newswire June 3, 2021

Enveric Biosciences and MagicMed to Participate in June 2021 Investor and Industry Conferences

PR Newswire June 3, 2021

AgBiome Grows Commercial Team with Four Strategic Hires

PR Newswire June 3, 2021

Sandwalk BioVentures and CosmosID Launch Joint GRAS Genomic Reporting Service

PR Newswire June 3, 2021